Alnylam Pharmaceuticals (Nasdaq: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.
Recent Mentions on Fool.com
- Alnylam Pharmaceuticals is Selling Off Today -- But Why?
- Alnylam Pharmaceuticals' Stock Picked Up Steam in November: Any Upside Remaining?
- These 3 Biotechs Are Winning in the Clinic
- Alnylam Pharmaceuticals, Inc. Earnings: 100% Positive (Data)
- These 2 Companies Could Revolutionize Heart Disease Prevention